Gene Salkind
CIK 1592481 · last filed 2026-07-20
Gene Salkind is a corporate insider who has filed 44 SEC Form 4 insider transactions across 5 companies since 2020. The most recent filing, for UPXI, was dated Jul 20, 2026. Across all open-market trades the lifetime net is +$1.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $432.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$432.1K
5
44
$1.86M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UPXI | Director | 537,500 | $0.80 | $432.1K | $1.32M | 6 | 2026-07-20 |
| Z Squared Inc. (COEPW) Delisted | Director | 17,207 | $0.01 | $179 | $38.1K | 5 | 2026-02-13 |
| Mobiquity Technologies, Inc. (MOBQW) Delisted | Director | 448,535 | $0.01 | $3.5K | $0 | 8 | 2023-11-09 |
| UPEXI, INC. (GRVI) Delisted | Director | 2,477,942 | $4.95 | $12.27M | $500.0K | 2 | 2022-04-01 |
| DermTech, Inc. (DMTK) Delisted | Director | 179,154 | $0.09 | $16.8K | $0 | 2 | 2020-02-03 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-20 | UPXI | Grant (A) | +100,000 | $0 | EDGAR |
| 2026-02-13 | Z Squared Inc. (COEPW) Delisted | Mixed | +8,950 | $60.2K | EDGAR |
| 2026-01-02 | — | Grant (A) | — | $0 | |
| 2025-11-21 | UPXI | Buy (P) | +50,000 | $127.5K | EDGAR |
| 2025-11-18 | UPXI | Buy (P) | +200,000 | $546.0K | EDGAR |
| 2025-09-19 | — | Grant (A) | +25,000 | $25.0K | |
| 2025-07-30 | UPXI | Mixed | +220,243 | $100.0K | EDGAR |
| 2025-04-25 | UPXI | Mixed | +241,229 | $550.0K | EDGAR |
| 2025-03-06 | Z Squared Inc. (COEPW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-02 | — | Exer (X) | +420,000 | $210.0K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.